Vistagen Therapeutics, Inc. (VTGN): Weighted Average Diluted Shares
38.07M
Year ended 2026-03-31
+76.2%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | 38.07M | +23.3% | 2026-06-15, From 2025-04-01 |
| 2025-03-31 | 30.88M | +59.5% | 2026-06-15, From 2024-04-01 |
| 2024-03-31 | 19.35M | +178.1% | 2025-06-17, From 2023-04-01 |
| 2023-03-31 | 6.96M | n/c | 2024-06-11, From 2022-04-01 |
| No annual figure between 2016-03-31 and 2023-03-31. | |||
| 2016-03-31 | 1.77M | +34.1% | 2016-06-24, From 2015-04-01 |
| 2015-03-31 | 1.32M | +20.0% | 2016-06-24, From 2014-04-01 |
| 2014-03-31 | 1.10M | -93.9% | 2015-06-29, From 2013-04-01 |
| 2013-03-31 | 18.11M | +22.9% | 2014-06-25, From 2012-04-01 |
| 2012-03-31 | 14.74M | +181.2% | 2013-07-18, From 2011-04-01 |
| 2011-03-31 | 5.24M | n/a | 2012-07-02, From 2010-04-01 |